FR2096902A1 - Aqs alcoholic extract of chrysanthellum americanum vatke - - active in intestinal disorders - Google Patents

Aqs alcoholic extract of chrysanthellum americanum vatke - - active in intestinal disorders

Info

Publication number
FR2096902A1
FR2096902A1 FR7025949A FR7025949A FR2096902A1 FR 2096902 A1 FR2096902 A1 FR 2096902A1 FR 7025949 A FR7025949 A FR 7025949A FR 7025949 A FR7025949 A FR 7025949A FR 2096902 A1 FR2096902 A1 FR 2096902A1
Authority
FR
France
Prior art keywords
active
extract
vatke
aqs
intestinal disorders
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7025949A
Other languages
English (en)
French (fr)
Other versions
FR2096902B1 (OSRAM
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to FR7025949A priority Critical patent/FR2096902A1/fr
Publication of FR2096902A1 publication Critical patent/FR2096902A1/fr
Application granted granted Critical
Publication of FR2096902B1 publication Critical patent/FR2096902B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)
FR7025949A 1970-07-15 1970-07-15 Aqs alcoholic extract of chrysanthellum americanum vatke - - active in intestinal disorders Granted FR2096902A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7025949A FR2096902A1 (en) 1970-07-15 1970-07-15 Aqs alcoholic extract of chrysanthellum americanum vatke - - active in intestinal disorders

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7025949A FR2096902A1 (en) 1970-07-15 1970-07-15 Aqs alcoholic extract of chrysanthellum americanum vatke - - active in intestinal disorders

Publications (2)

Publication Number Publication Date
FR2096902A1 true FR2096902A1 (en) 1972-03-03
FR2096902B1 FR2096902B1 (OSRAM) 1973-08-10

Family

ID=9058677

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7025949A Granted FR2096902A1 (en) 1970-07-15 1970-07-15 Aqs alcoholic extract of chrysanthellum americanum vatke - - active in intestinal disorders

Country Status (1)

Country Link
FR (1) FR2096902A1 (OSRAM)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2801186A1 (de) * 1977-01-20 1978-07-27 Sarget Lab Pflanzlicher extrakt aus chrysantellum-arten, verfahren zu seiner herstellung sowie den extrakt enthaltende arzneimittel
FR2579907A1 (en) * 1985-04-09 1986-10-10 Couderc Pierre Method for enriching chrysantellum with active ingredients by physical processes
FR2618071A1 (fr) * 1987-07-17 1989-01-20 Guillot Bernard Compositions cosmetiques et dermatologiques a base d'extraits de chrysanthellum
EP0317453A1 (fr) * 1987-11-19 1989-05-24 IPHYM SA Société Anonyme dite : Compositions médicamenteuses à base de flavonoides et de saponines extraits de chrysanthellum, leur procédé de préparation et applications thérapeutiques
EP0968709A1 (fr) * 1998-07-03 2000-01-05 Lanatech Laboratoire Nature et Technique Composition cosmetique exploitant des effets antiradicalaires synergiques
CN106619654A (zh) * 2016-12-27 2017-05-10 广西中医药大学 齐墩果酸在制备治疗痛风药物中的应用
IT202100002735A1 (it) 2021-02-08 2022-08-08 Phytoitalia Srl Metodo di estrazione e arricchimento di flavonoidi monoglicosilati da chrysanthellum indicum per il trattamento di patologie poliartritiche su base infiammatoria, per l'uso in dispositivi cosmetici, nutraceutici, medici e applicazioni farmaceutiche

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2801186A1 (de) * 1977-01-20 1978-07-27 Sarget Lab Pflanzlicher extrakt aus chrysantellum-arten, verfahren zu seiner herstellung sowie den extrakt enthaltende arzneimittel
FR2579907A1 (en) * 1985-04-09 1986-10-10 Couderc Pierre Method for enriching chrysantellum with active ingredients by physical processes
FR2618071A1 (fr) * 1987-07-17 1989-01-20 Guillot Bernard Compositions cosmetiques et dermatologiques a base d'extraits de chrysanthellum
EP0317453A1 (fr) * 1987-11-19 1989-05-24 IPHYM SA Société Anonyme dite : Compositions médicamenteuses à base de flavonoides et de saponines extraits de chrysanthellum, leur procédé de préparation et applications thérapeutiques
FR2623398A1 (fr) * 1987-11-19 1989-05-26 Iphym Sa Compositions medicamenteuses a base de flavonoides et de saponines extraits de chrysanthellum. procede de preparation et applications therapeutiques
EP0968709A1 (fr) * 1998-07-03 2000-01-05 Lanatech Laboratoire Nature et Technique Composition cosmetique exploitant des effets antiradicalaires synergiques
FR2780647A1 (fr) * 1998-07-03 2000-01-07 Lanatech Composition cosmetique exploitant des effets antiradicalaires synergiques
CN106619654A (zh) * 2016-12-27 2017-05-10 广西中医药大学 齐墩果酸在制备治疗痛风药物中的应用
IT202100002735A1 (it) 2021-02-08 2022-08-08 Phytoitalia Srl Metodo di estrazione e arricchimento di flavonoidi monoglicosilati da chrysanthellum indicum per il trattamento di patologie poliartritiche su base infiammatoria, per l'uso in dispositivi cosmetici, nutraceutici, medici e applicazioni farmaceutiche
EP4039332A1 (en) 2021-02-08 2022-08-10 Phytoitalia SRL Method of extraction and enrichment of monoglycosylated flavonoids from chrysanthellum indicum for the treatment of inflammatory-based polyarthritic disorders, for use in cosmetic, nutraceutical and medical devices and pharmaceutical applications

Also Published As

Publication number Publication date
FR2096902B1 (OSRAM) 1973-08-10

Similar Documents

Publication Publication Date Title
OA09023A (fr) Composition pharmaceutique, administrable par voie orale, destinée à réduire les effets des b-lactamines.
BE777689A (fr) Nouveaux derives de l'imidazoline, compositions therapeutiques les contenant ainsi que le procede de preparation de ces derives et de ces compositions
ES8307494A1 (es) "un procedimiento para preparar una composicion farmaceutica que proporciona un efecto anti-inflamatorio y analgesico junto con un dano gastrico minimizado".
ES382842A1 (es) Procedimiento para la preparacion de piperazinilalcohilami-no - uracilos, uracileteres y uraciltioeteres aril-sustitui-dos.
FR2096902A1 (en) Aqs alcoholic extract of chrysanthellum americanum vatke - - active in intestinal disorders
FR2417494A1 (fr) Nouvelles compositions analgesiques et antipyretiques contenant un derive de paracetamol
GB1049996A (en) New medicine with anti-inflammatory and anti-rheumatic activity
GB1511196A (en) Creatinine pyrolidonecarboxylate
GB980436A (en) The acid salt composed of acetyl glutamic acid and n,n-dimethylaminoethanol-1 and preparation of same
GB1269616A (en) Improvements in pharmaceutical compositions
JPS54151134A (en) Antitumorigenic agent
KAWATA et al. Threatment of Tricomonas Vaginitis with Trichothamin (2-Acetylamino-5-nitrothiazole)
FR2243679A1 (en) Antiinflammatory 1,2-dihydroquinoline derivs - prepd by condensn of acetone with substd aniline
FR289M (fr) Médicament utilisable dans le traitement de l'hypercholestérolémie et des états apparentés, a base de dérivés de la thyronine.
FR2074736A1 (en) Choline dehydrocholate - for treating hepatic and biliary disorders
FR1221M (fr) Traitement homéoflore des troubles digestifs de l'estomac, du foie, de l'intestin, des douleurs occasionnées par ces troubles des déficiences rénales.
FUKUSHIMA My Polysaccharide Therapy of Haman Cancer and the Study on Polysaccharide by Hamashima et al
GB918066A (en) 1,2-diphenyl-4-carbamoyl-3,5-pyrazolidinedione and salts
FR2103006A6 (en) Choline dehydrocholate - for treating hepatic and biliary disorders
JPS5498339A (en) Carcinostatic agent
Furusawa et al. Investigation on the Time Schedule and the Nutritional Intake of Junior College Students
FR2081559A1 (en) 1-(p-chlorophenyl)-4-(3-aroylamino-butyl)-piperazines - useful as anti-histamines and spasmolytics
Forest Investigations of amino acid metabolism in Phaseolus vulgaris L. in relation to the development of transaminase activity during germination and the properties of an aromatic aminotransferase purified from roots.
AR022475A1 (es) Metodo para la prevencion o reduccion de eventos cardiovasculares asociados con intervencion coronaria.
GB1036059A (en) Improvements in or relating to the inhibition of bacterial growth

Legal Events

Date Code Title Description
TP Transmission of property
TP Transmission of property
CD Change of name or company name
TP Transmission of property